Chin Mark
- SEC CIK
- 0001734389
No open-market purchases or sales filed in the past year.
Current role at each company
- IRON Disc Medicine, Inc.Directoras of Jun 23, 2026
- HARP Harpoon Therapeutics, Inc.Directoras of Mar 11, 2024
- ITRM Iterum Therapeutics plcDirectoras of Jun 15, 2023
- ELVN Enliven Therapeutics, Inc.Directoras of Jun 3, 2022
- PYXS Pyxis Oncology, Inc.Other: Former Directoras of Apr 25, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Chin Mark as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PYXS Pyxis Oncology, Inc.
Other: Former Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 25, 2022 (view filing) | Apr 21 | 4 days | Chin MarkOther: Former Director | SSale | −1.75M | $3.05 | −$5.32M | −100.0%0 after | |
| Oct 15, 2021 (view filing) | Oct 13 | 2 days | Chin MarkDirector | PPurchase | +312.5K | $16.00 | +$5.00M | +21.8%1.75M after |
ELVN Enliven Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 28, 2021 (view filing) | Jul 16 | 12 daysLate | Chin MarkDirector | PPurchase | +1.33M | $6.00 | +$8.00M | +131.9%2.34M after |